CDC
Booster Support
A US Centers for Disease Control and Prevention advisory committee has indicated its support for booster doses of SARS-CoV-2 vaccines, according to the Wall Street Journal.
CDC's Slow Sharing
Critics tell the Washington Post that the US Centers for Disease Control and Prevention has been too slow to release needed data on Delta SARS-CoV-2 variant.
Boosters for the US
NPR reports that US adults who received either the Pfizer-BioNTech or Moderna SARS-CoV-2 vaccines will be eligible for a booster shot.
Delta's Reach in the US
The Centers for Disease Control and Prevention says the Delta variant accounts for 83 percent of all sequenced COVID-19 cases in the US, according to CNBC.
Another Dose for Immunocompromised Considered
The Washington Post reports that a US advisory panel is to consider whether the data supports an additional vaccine dose for immunocompromised individuals.